Omar Ali, MD
Interventional Pain Medicine · Springfield, OHNPI 1437545050
Payments from drug & device makers
What this record shows
This record is dominated by grants: $56,250 of the $66,641 with a category attached, or 84.4%. Boston Scientific accounts for 74.3% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2019 at $56,763 and has fallen 97.2% since, to $1,562 in 2025. Among interventional pain medicine clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 338 payments — averaging $197.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$50K
- Medtronic$11K
- Vertos Medical, Inc.$1K
- Abbott$1K
- Collegium Pharmaceutical, Inc.$505
- Stryker$406
- plus $3K from 25 others
What the payments were for
- Grants$56,25084%
- Travel & lodging$6391%
- Food & beverage$9,45214%
- Education$3000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 153 | $49,504 |
| Medtronic(2 entities) | 8 | $11,477 |
| Vertos Medical, Inc. | 21 | $1,051 |
| Abbott | 20 | $1,010 |
| Collegium Pharmaceutical, Inc. | 32 | $505 |
| Stryker | 5 | $406 |
| Biotronik NRO, Inc. | 13 | $403 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 24 | $400 |
| Straumann USA LLC | 9 | $300 |
| Amgen | 7 | $206 |
| SPR Therapeutics, Inc | 3 | $196 |
| Saluda Medical Americas, Inc. | 2 | $159 |
| Tersera Therapeutics LLC | 6 | $140 |
| Vertex | 5 | $128 |
| Flowonix Medical Incorporated | 1 | $124 |
| Spinefrontier, Inc. | 1 | $115 |
| Lundbeck LLC | 5 | $84 |
| Avanos Medical | 1 | $64 |
| AbbVie | 3 | $52 |
| Pfizer | 3 | $48 |
| Stimwave Technologies Incorporated | 3 | $46 |
| Curonix LLC | 2 | $36 |
| Valinor Pharma, LLC | 2 | $30 |
| Lilly USA, LLC | 2 | $30 |
| Tonix Medicines, Inc. | 1 | $27 |
| Arbor Pharmaceuticals, Inc. | 1 | $23 |
| Convatec Inc. | 1 | $18 |
| Si-bone, Inc. | 1 | $17 |
| Spinal Simplicity, LLC | 1 | $15 |
| IBSA Pharma Inc. | 1 | $15 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPECTRA WAVEWRITER$45,449
- SYNCHROMED$11,250
- mild Device Kit$758
- WaveWriter Alpha Prime 16$566
- Proclaim IPG$477
- Prospera$266
- Superion Indirect Decompression System$217
- SPRINT PNS System$161
- Evoke$144
- Octrode SCS Leads$140
- Prometra II$124
- Proclaim Family of SCS IPGs$119
- GENERAL PAIN MANAGEMENT$116
- InSpan$115
- SacroFuse$115
- NanoFuse Putty$115
- Intracept$115
- GENERAL - THERAPIES$112
- KRYSTEXXA$102
- VERTIFLEX SUPERION$102
How this compares
$66,641 in reported general payments places this provider in the 90th percentile of 67 interventional pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 565 | $14,582 |
| MovantikNaloxegol Oxalate | 27 | $11,285 |
| Xtampza ErOxycodone Myristate | 20 | $10,186 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 424 | $8,233 |
| Gabapentin | 486 | $6,464 |
| Pregabalin | 179 | $4,070 |
| Tizanidine Hcl | 329 | $3,838 |
| Naloxone Hcl | 38 | $2,277 |
| Lidocaine | 34 | $2,163 |
| Celecoxib | 39 | $2,155 |
| Oxycodone Hcl | 126 | $1,882 |
| Buprenorphine | 11 | $1,689 |
| Tramadol Hcl | 144 | $1,342 |
| Morphine Sulfate ErMorphine Sulfate | 64 | $1,201 |
| Methocarbamol | 104 | $969 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $505 | $10,18620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 67 interventional pain medicine providers in Ohio.
Other interventional pain medicine in Springfield
- Gladstone McDowellColumbus$660K
- Humam AkbikFairfield$116K
- Sara NashiCincinnati$116K
- Jaudat MahmoodKent$97K
- Dustin ReynoldsWesterville$61K
- James OttingToledo$47K
- Mark MalinowskiChillicothe$39K
- David WalegaColumbus$37K
- Ronald LinehanLancaster$26K
- Vivekanand ManochaMason$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.